This case involves a fifty-three-year-old patient who presented to his urologist complaining of recent sexual dysfunction. He also complained of sleep disturbances, fatigue, and lower back pain. The urologist advised the patient that he may be suffering from low testosterone and would likely benefit from using AndroGel “trt,” or therapeutic testosterone cream. The physician only performed a physical exam on the patient but neglected to screen his blood for a baseline PSA value. Three months later, the patient returned with reports of improved sexual function but now complained of new urinary symptoms associated with occasional blood in the urine. Subsequently, the patient was found to have advanced prostate cancer.
Question(s) For Expert Witness
1. Does this medication increase a patient's risk for cancer?
Expert Witness Response E-000182
AndroGel is an androgen hormone indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. It is widely accepted in the medical community that patients treated with androgens may be at increased risk for prostate cancer and it is of utmost importance to evaluate patients for possible prostate cancer prior to initiating and during treatment with androgen therapy. It is negligent to blindly prescribe this medication without first screening a patient and determining a baseline PSA.
About the author
Michael Talve, CEO
Michael Talve stands at the forefront of legal innovation as the CEO and Managing Director of Expert Institute. Under his leadership, the Expert Institute has established itself as a vital player in the legal technology arena, revolutionizing how lawyers connect with world-class experts and access advanced legal technology. Michael's role involves not only steering the company's strategic direction but also ensuring the delivery of unparalleled intelligence and cutting-edge solutions to legal professionals. His work at Expert Institute has been instrumental in enhancing the capabilities of attorneys in case preparation and execution, making a significant impact on the legal industry's approach to expert consultation and technological integration. Michael's vision and execution have positioned the Expert Institute as a key facilitator in the intersection of law and technology.
